164 related articles for article (PubMed ID: 38499969)
1. Cutaneous lymphoproliferative disorders: Back to the future.
Willemze R
J Cutan Pathol; 2024 Jun; 51(6):468-476. PubMed ID: 38499969
[TBL] [Abstract][Full Text] [Related]
2. Classifications of cutaneous lymphomas and lymphoproliferative disorders: An update from the EORTC cutaneous lymphoma histopathology group.
Kempf W; Mitteldorf C; Cerroni L; Willemze R; Berti E; Guenova E; Scarisbrick JJ; Battistella M
J Eur Acad Dermatol Venereol; 2024 Apr; ():. PubMed ID: 38581201
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous pseudolymphomas: classification and differential diagnosis.
Rijlaarsdam JU; Willemze R
Semin Dermatol; 1994 Sep; 13(3):187-96. PubMed ID: 7986687
[TBL] [Abstract][Full Text] [Related]
4. CD27/CD70 pathway activation in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Richter J; Oschlies I; Kock K; Wüseke T; Haag J; Koch K; Klapper W
J Pathol; 2024 Feb; 262(2):189-197. PubMed ID: 37933684
[TBL] [Abstract][Full Text] [Related]
5. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
6. C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment.
Geller S; Hollmann TJ; Horwitz SM; Myskowski PL; Pulitzer M
Histopathology; 2020 Jan; 76(2):222-232. PubMed ID: 31355940
[TBL] [Abstract][Full Text] [Related]
7. [Immunoglobulin heavy chain gene rearrangement study in difficult cases of B-cell lymphoproliferative disorder].
Wang Q; Li XQ; Zhu XZ; Zhu XL; Lu HF; Zhang TM; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):296-301. PubMed ID: 20654151
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous T-cell lymphoma (CTCL), rare subtypes: five case presentations and review of the literature.
Geller S; Myskowski PL; Pulitzer M; Horwitz SM; Moskowitz AJ
Chin Clin Oncol; 2019 Feb; 8(1):5. PubMed ID: 30525759
[TBL] [Abstract][Full Text] [Related]
9. Clonal B-cell proliferations developing in the background of primary cutaneous CD4
Ates Ozdemir D; Akdoğan N; Okay M; Uner A; Saglam A
J Cutan Pathol; 2022 Nov; 49(11):971-977. PubMed ID: 35871674
[TBL] [Abstract][Full Text] [Related]
10. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
11. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.
Willemze R; Cerroni L; Kempf W; Berti E; Facchetti F; Swerdlow SH; Jaffe ES
Blood; 2019 Apr; 133(16):1703-1714. PubMed ID: 30635287
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in cutaneous lymphoma-implications for current and future classifications.
Goodlad JR; Cerroni L; Swerdlow SH
Virchows Arch; 2023 Jan; 482(1):281-298. PubMed ID: 36278991
[TBL] [Abstract][Full Text] [Related]
13. Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis.
Obiorah IE; Karrs J; Brown L; Wang HW; Karai LJ; Pham TH; Pham TA; Xi L; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2023 Mar; 47(3):344-353. PubMed ID: 36598455
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
15. [New aspects in the classification of cutaneous lymphomas].
Erós N; Károlyi Z; Kovács A
Orv Hetil; 2001 Feb; 142(8):393-8. PubMed ID: 11263077
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features.
Baldassano MF; Bailey EM; Ferry JA; Harris NL; Duncan LM
Am J Surg Pathol; 1999 Jan; 23(1):88-96. PubMed ID: 9888708
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 expression, cell proliferation, and clonal persistence characterize primary cutaneous CD4
Oschlies I; Kock K; Wüseke T; Richter J; Koch K; Wehkamp U; Klapper W
Histopathology; 2023 Feb; 82(3):485-494. PubMed ID: 36341542
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up and management of small and medium-sized CD4
Virmani P; Jawed S; Myskowski PL; Horwitz S; Skripnik Lucas A; Moskowitz A; Pulitzer M; Zain J; Rosen ST; Querfeld C
Int J Dermatol; 2016 Nov; 55(11):1248-1254. PubMed ID: 27369070
[TBL] [Abstract][Full Text] [Related]
19. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
Cetinözman F; Jansen PM; Willemze R
Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
